Boston Scientific shareholders approve bylaw amendments and elect directors at annual meeting

BOSTON SCIENTIFIC CORP

All nine director nominees elected with votes ranging from 1.17B to 1.25B in favor.
Amendment to bylaws approved (1.24B for, 6.55M against); updates advance notice period to 90-120 days and universal proxy rule compliance.
Say-on-pay non-binding advisory vote approved: 1.16B for, 90.95M against.
Ratification of Ernst & Young as auditor for 2024: 1.22B for, 105.62M against.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

BOSTON SCIENTIFIC CORP: Amendment and restatement of By-Laws to provide for advance notice and universal proxy rule updates, including expanded disclosures, revised advance notice period, and compliance requirements for Rule 14a-19, effective May 2, 2024 (effective 2024-05-02).

Change: bylaw amendment
Effective: 2024-05-02

Exact text from the filing

The By-Laws, as so amended and restated, became effective May 2, 2024.

View on SEC.gov

263 governance changes filed in the last 30 days. Browse all governance changes →

BOSTON SCIENTIFIC CORP filing history →

Source: SEC EDGAR

accession 0000885725-24-000048

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.